Injury-Mediated Vascular Regeneration Requires Endothelial ER71/ETV2

Objective— Comprehensive understanding of the mechanisms regulating angiogenesis might provide new strategies for angiogenic therapies for treating diverse physiological and pathological ischemic conditions. The E-twenty six (ETS) factor Ets variant 2 (ETV2; aka Ets-related protein 71) is essential for the formation of hematopoietic and vascular systems. Despite its indispensable function in vessel development, ETV2 role in adult angiogenesis has not yet been addressed. We have therefore investigated the role of ETV2 in vascular regeneration. Approach and Results— We used endothelial Etv2 conditional knockout mice and ischemic injury models to assess the role of ETV2 in vascular regeneration. Although Etv2 expression was not detectable under steady-state conditions, its expression was readily observed in endothelial cells after injury. Mice lacking endothelial Etv2 displayed impaired neovascularization in response to eye injury, wounding, or hindlimb ischemic injury. Lentiviral Etv2 expression in ischemic hindlimbs led to improved recovery of blood perfusion with enhanced vessel formation. After injury, fetal liver kinase 1 (Flk1), aka VEGFR2, expression and neovascularization were significantly upregulated by Etv2, whereas Flk1 expression and vascular endothelial growth factor response were significantly blunted in Etv2-deficient endothelial cells. Conversely, enforced Etv2 expression enhanced vascular endothelial growth factor–mediated endothelial sprouting from embryoid bodies. Lentiviral Flk1 expression rescued angiogenesis defects in endothelial Etv2 conditional knockout mice after hindlimb ischemic injury. Furthermore, Etv2 +/−; Flk1 +/− double heterozygous mice displayed a more severe hindlimb ischemic injury response compared with Etv2 +/− or Flk1 +/− heterozygous mice, revealing an epistatic interaction between ETV2 and FLK1 in vascular regeneration. Conclusions— Our study demonstrates a novel obligatory role for the ETV2 in postnatal vascular repair and regeneration.

[1]  Daofeng Li,et al.  Induction of hematopoietic and endothelial cell program orchestrated by ETS transcription factor ER71/ETV2 , 2015, EMBO reports.

[2]  D. Balciunas,et al.  Etv2 and Fli1b Function Together as Key Regulators of Vasculogenesis and Angiogenesis , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[3]  Nana Shimizu,et al.  ETS transcription factor ETV2 directly converts human fibroblasts into functional endothelial cells , 2014, Proceedings of the National Academy of Sciences.

[4]  Hyun-Jai Cho,et al.  Direct Conversion of Adult Skin Fibroblasts to Endothelial Cells by Defined Factors , 2014, Circulation.

[5]  A. Eichmann,et al.  Transmembrane protein ESDN promotes endothelial VEGF signaling and regulates angiogenesis. , 2013, The Journal of clinical investigation.

[6]  B. Lévy,et al.  Postischemic revascularization: from cellular and molecular mechanisms to clinical applications. , 2013, Physiological reviews.

[7]  Joshua D. Wythe,et al.  ETS factors regulate Vegf-dependent arterial specification. , 2013, Developmental cell.

[8]  Shuo Lin,et al.  Transdifferentiation of Fast Skeletal Muscle Into Functional Endothelium in Vivo by Transcription Factor Etv2 , 2013, PLoS biology.

[9]  Yosuke Tanaka,et al.  Region-specific Etv2 ablation revealed the critical origin of hemogenic capacity from Hox6-positive caudal-lateral primitive mesoderm. , 2013, Experimental hematology.

[10]  D. Garry,et al.  VEGF/Flk1 Signaling Cascade Transactivates Etv2 Gene Expression , 2012, PloS one.

[11]  Olivier Elemento,et al.  Efficient Direct Reprogramming of Mature Amniotic Cells into Endothelial Cells by ETS Factors and TGFβ Suppression , 2012, Cell.

[12]  Yosuke Tanaka,et al.  Endothelialization and altered hematopoiesis by persistent Etv2 expression in mice. , 2012, Experimental hematology.

[13]  Hans Clevers,et al.  Wnt/β-Catenin Signaling and Disease , 2012, Cell.

[14]  S. Artavanis-Tsakonas,et al.  Notch and disease: a growing field. , 2012, Seminars in cell & developmental biology.

[15]  J. Nerbonne,et al.  ER71 specifies Flk-1+ hemangiogenic mesoderm by inhibiting cardiac mesoderm and Wnt signaling. , 2012, Blood.

[16]  Yosuke Tanaka,et al.  Etv2/ER71 induces vascular mesoderm from Flk1+PDGFRα+ primitive mesoderm. , 2011, Blood.

[17]  B. Black,et al.  FGF-dependent regulation of VEGF receptor 2 expression in mice. , 2011, The Journal of clinical investigation.

[18]  F. Müller,et al.  Xenopus er71 is involved in vascular development , 2010, Developmental dynamics : an official publication of the American Association of Anatomists.

[19]  H. Gerhardt,et al.  Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting , 2010, Nature Cell Biology.

[20]  L. Liaw,et al.  The contribution of the Tie2+ lineage to primitive and definitive hematopoietic cells , 2010, Genesis.

[21]  Shaheynoor Talukder,et al.  Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo , 2010, The EMBO journal.

[22]  Thomas Korff,et al.  Evaluation of postnatal arteriogenesis and angiogenesis in a mouse model of hind-limb ischemia , 2009, Nature Protocols.

[23]  Michael C. Ostrowski,et al.  Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis. , 2009, Blood.

[24]  Robert A. Weinberg,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[25]  R. Hammer,et al.  Nkx2–5 transactivates the Ets-related protein 71 gene and specifies an endothelial/endocardial fate in the developing embryo , 2009, Proceedings of the National Academy of Sciences.

[26]  A. Visel,et al.  Combinatorial Regulation of Endothelial Gene Expression by Ets and Forkhead Transcription Factors , 2008, Cell.

[27]  M. Kyba,et al.  ER71 acts downstream of BMP, Notch, and Wnt signaling in blood and vessel progenitor specification. , 2008, Cell stem cell.

[28]  Shuo Lin,et al.  Interplay among Etsrp/ER71, Scl, and Alk8 signaling controls endothelial and myeloid cell formation. , 2008, Blood.

[29]  E. Dejana,et al.  Foxs and Ets in the transcriptional regulation of endothelial cell differentiation and angiogenesis. , 2007, Biochimica et biophysica acta.

[30]  B. Weinstein,et al.  Combinatorial function of ETS transcription factors in the developing vasculature. , 2007, Developmental biology.

[31]  M. Kyba,et al.  GATA2 functions at multiple steps in hemangioblast development and differentiation , 2007, Development.

[32]  R. Apte,et al.  Macrophages Inhibit Neovascularization in a Murine Model of Age-Related Macular Degeneration , 2006, PLoS medicine.

[33]  J. Kreuger,et al.  Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis. , 2006, Developmental cell.

[34]  P. Carmeliet,et al.  VE‐Cadherin‐Cre‐recombinase transgenic mouse: A tool for lineage analysis and gene deletion in endothelial cells , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[35]  Shuo Lin,et al.  Ets1-Related Protein Is a Key Regulator of Vasculogenesis in Zebrafish , 2005, PLoS biology.

[36]  Bart Landuyt,et al.  Vascular Endothelial Growth Factor and Angiogenesis , 2004, Pharmacological Reviews.

[37]  S. Horiuchi,et al.  N(epsilon)-(carboxymethyl)lysine proliferated CD34(+) cells from rat choroidal explant in culture. , 2004, Biological & pharmaceutical bulletin.

[38]  I. Thorey,et al.  Transgenic Mice Reveal Novel Activities of Growth Hormone in Wound Repair, Angiogenesis, and Myofibroblast Differentiation* , 2004, Journal of Biological Chemistry.

[39]  T. Peto,et al.  The epidemiology of age-related macular degeneration. , 2004, American journal of ophthalmology.

[40]  M. Burnett,et al.  Temporal patterns of gene expression after acute hindlimb ischemia in mice: insights into the genomic program for collateral vessel development. , 2004, Journal of the American College of Cardiology.

[41]  Mark Coles,et al.  Transgenic mice with hematopoietic and lymphoid specific expression of Cre , 2003, European journal of immunology.

[42]  F. Peale,et al.  Time course of skeletal muscle repair and gene expression following acute hind limb ischemia in mice. , 2002, Physiological genomics.

[43]  R. Hammer,et al.  Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. , 2001, Developmental biology.

[44]  D. Watson,et al.  Hemorrhage, Impaired Hematopoiesis, and Lethality in Mouse Embryos Carrying a Targeted Disruption of the Fli1Transcription Factor , 2000, Molecular and Cellular Biology.

[45]  J. Isner,et al.  Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice. , 1999, Circulation.

[46]  J. Isner,et al.  Mouse model of angiogenesis. , 1998, The American journal of pathology.

[47]  J. Visvader,et al.  Transcriptional regulation of vav, a gene expressed throughout the hematopoietic compartment. , 1998, Blood.

[48]  Leonard,et al.  Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. , 1997, Cancer research.

[49]  Kenneth J. Hillan,et al.  Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene , 1996, Nature.

[50]  Lieve Moons,et al.  Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele , 1996, Nature.

[51]  Janet Rossant,et al.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.

[52]  K. Alitalo,et al.  Vascularization of the mouse embryo: A study of flk‐1, tek, tie, and vascular endothelial growth factor expression during development , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[53]  J. Rommens,et al.  Physical mapping at a potential X-linked retinitis pigmentosa locus (RP3) by pulsed-field gel electrophoresis. , 1991, Genomics.

[54]  Seong Ho Pahng,et al.  Supplemental Information Enhanced Hemangioblast Generation and Improved Vascular Repair and Regeneration from Embryonic Stem Cells by Defined Transcription Factors , 2013 .

[55]  Peter C. Hollenhorst,et al.  Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors. , 2004, Nucleic acids research.

[56]  J. Shelton,et al.  Rationale: Cardiovascular Health Depends on Proper Development and Integrity of Blood Vessels. Ets Variant 2 (etv2), Methods and Results: Using Loss-and Gain-of-function Strategies and a Series of Molecular Techniques, We Identify Friend Leukemia Integration 1 (fli1), Another E26 Transforming–specif , 2022 .